Document is current
Any future updates will be listed below
-
Authors
Hu, Rong
Zhao, Jin
Lai, Kuan Chen
Wang, Shikun
Zheng, Jianqing
Stoddard, Christopher
Lai, Laijun https://orcid.org/0000-0002-4581-7642
-
Funding
Funding for this research was provided by:
NIH (R01AI175087, R33AG072234)
- License Information
-
More Information
Article History
Received: 30 August 2024
Accepted: 10 June 2025
First Online: 17 June 2025
Declarations
:
: The H9 hESCs were obtained from the WiCell Research Institute under a material transfer agreement (WeCell Agreement No. 12-WO0384). The hESCs were used according to a protocol titled “Treating T cell immunodeficiency in CHARGE syndrome by ESC- and iPSC-derived thymic epithelial cells” approved by the Stem Cell Research Oversight Committee at the University of Connecticut (SCRO #2023-2, approval day 2/23/2023).
: Not applicable.
: The authors declare no competing interests.
